Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: Role of nitric oxide and prostaglandin

Hepatology

Volumn 30, Issue 3, 1999, Pages 630-635

  Chan, Che Chang ^b   Lee, Fa Yauh ^a   Wang, Sun Sang ^b   Chang, Full Young ^b   Lin, Han Chieh ^b   Chu, Chi Jen ^b   Tai, Chun Ching ^b   Lai, I Nien ^b   Lee, Shou Dong ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN DERIVATIVE; ARGIPRESSIN[1 DEAMINO]; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; PROSTAGLANDIN; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; COLLATERAL CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT;

ANIMALS; COLLATERAL CIRCULATION; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION, PORTAL; INDOMETHACIN; MALE; NITRIC OXIDE; NITROARGININE; PORTAL SYSTEM; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; VASOPRESSINS;

EID: 0032858372     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300317     Document Type: Article

References (20)

1. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodés J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and hemodynamic correlations in 100 patients. J Hepatol 1985;1:125-139.
2. Conn HO. Vasopressin and nitroglycerin in the treatment of bleeding varices: the bottom line. HEPATOLOGY 1986;6:523-525.
3. Altura BM, Altura BT. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc 1977;36:1853-1860.
4. Texter EC Jr, Chou CC, Merrill SL, Laurela HC, Frohlich ED. Direct effects of vasoactive agents on segmental resistance of the mesenteric and portal circulation. J Lab Clin Med 1964;64:624-633.
5. Busse R, Mülsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993;87(Suppl 5):V18-V25.
6. Smith WL. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol 1986;48:251-262.
7. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992;103:235-239.
8. ω-nitro-L-arginine ameliorates portal-systemic shunting in portal -hypertensive rats. Gastroenterology 1993;105:1464-1470.
9. Fernández M, García-Pagán JC, Casadevall M, Mourelle MI, Piqué JM, Bosch J, Rodés J. Acute and chronic cyclooxygenase blockade in portal-hypertensive rats: influence on nitric oxide biosynthesis. Gastroenterology 1996; 110:1529-1539.
10. Hou MC, Cahill PA, Zhang S, Wang YN, Hendrickson RJ, Redmond EM, Sitzmann JV. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation. HEPATOLOGY 1998;27:20-27.
11. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. HEPATOLOGY 1993;18:1416-1421.
12. Mosca P, Lee FY, Kaumann AJ, Groszmann RJ. Pharmacology of portal-systémic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol 1992;263:G544-G550.
13. Hamilton G, Phing RCF, Hutton RA, Dandona P, Hobbs KEF. The relationship between prostacyclin activity and pressure in the portal vein. HEPATOLOGY 1982;2:236-242.
14. Randall MD, Kay AP, Hiley CR. Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of rat. Br J Pharmacol 1988;95:646-652.
15. G-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac hemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br J Pharmacol 1991;102:65-72.
16. Chojker M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol 1981;240:G371-G375.
17. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985;248:G618-G625.
18. Hamilton RL, Berry MN, Williams MC, Severinghaus EM. A simple and inexpensive membrane "lung" for small organ perfusions. J Lipid Res 1974;15:182-186.
19. 8] vasopressin in the isolated perfused rat kidney. Eur J Pharmacol 1996;314:325-332.
20. Yang MCM, Yu PC, Tu MS, Lay CS, Hong CY, Chou CK, Chen CF. et al. Effects of endothelin and vasopressin on portal pressure of rats. Life Science 1990;46:1929-1936.